The Valvular Interventions Center

Filter Your Results

 

News

 

FDA Approves Abbott's Next-Generation MitraClip Device

July 12, 2018 -- Abbott Vascular announced approval from the FDA for the company's third-generation MitraClip transcatheter heart valve repair device. Abbott received Euro…

CMS to Convene MEDCAC Panel to Consider Procedural Volume Requirements for TAVR

July 2, 2018 -- The Centers for Medicare & Medicaid Services (CMS) will convene a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) on Ju…

Financing Will Support Development of TriCares' Tricuspid Valve Replacement System

July 2, 2018 -- TriCares SAS announced the successful completion of a €22 million ($25.4 million) Series B financing round, which will be used to advance product developm…

Enrollment Begins in CE Mark Study for JenaValve's Next-Generation TAVR System to Treat Severe Aortic Regurgitation

June 25, 2018 -- JenaValve Technology, Inc. announced initiation of patient enrollment in the CE Mark study of its next-generation JenaValve pericardial transcatheter aortic v…

Results of Quality-of-Life Assessment Published From the PARTNER S3i Trial

June 18, 2018 -- Suzanne J. Baron, MD, et al published findings from a study that sought to evaluate whether transcatheter aortic valve replacement (TAVR) with the Sapien 3 tr…

First North American Clinical Implantation of Venus Medtech's VenusP-Valve Performed in Canada

June 18, 2018 -- Venus Medtech Inc. announced the completion of the first two implantations in Canada of the VenusP-Valve self-expanding pulmonary valve device. The procedures…

Phase 2 of REFLECT Trial Begins for Keystone Heart’s TriGuard 3 Embolic Protection Device

June 18, 2018 -- Keystone Heart Ltd. recently announced the launch of phase 2 of the REFLECT trial to evaluate the safety and efficacy of the company's next-generation Tri…

Real-World Outcomes Reported for Edwards' Sapien 3 TAVR Device in Intermediate-Risk Patients

June 4, 2018 -- Edwards Lifesciences recently announced that 30-day data of outcomes in patients undergoing transcatheter aortic valve replacement with the company's Sapie…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.